Federal award

SIEMENS HEALTHCARE DIAGNOSTICS INC.

W91YTZ20P0097

Contract

Obligated and Ceiling

Obligated (net): $235,530.96
Ceiling (potential value, not spending): $235,530.96
Current value: $235,530.96
Gross positive obligations: $235,530.96

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient: SIEMENS HEALTHCARE DIAGNOSTICS INC. · GC14SNHB3JN1
Owner company: Not a reviewed companyNo reviewed company owns this recipient.
Reported parent: SIEMENS AKTIENGESELLSCHAFT · RDB2AM2GGHH8
Awarding agency: Department of War · sub-agency 2100 · office W91YTZ
Funding agency: Department of War · sub-agency 97DH
Product or service (PSC): 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS): 334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
PIID: W91YTZ20P0097
Award type code: B
Actions: 10 · Mar 18, 2020 to Oct 10, 2023
Why it is listed: gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History10

Award actions
Date	FY	Mod	Action type	Obligation	Company in company totals
Oct 10, 2023	FY2024	P00009	C	$50,762.16	—
Apr 17, 2023	FY2023	P00008	G	$0.00	—
Oct 12, 2022	FY2023	P00007	C	$50,762.16	—
Jun 8, 2022	FY2022	P00006	G	$0.00	—
Nov 4, 2021	FY2022	P00005	B	$7,101.24	—
Oct 22, 2021	FY2022	P00004	C	$50,762.16	—
Jun 24, 2021	FY2021	P00003	G	$0.00	—
Nov 5, 2020	FY2021	P00002	M	$50,762.16	—
Jun 26, 2020	FY2020	P00001	G	$0.00	—
Mar 18, 2020	FY2020	0	—	$25,381.08	—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.